Capabilities by Region: Continental Europe
Greenhill has considerable advisory experience in Continental Europe. Our Managing Directors and professionals have advised clients on transactions involving many of the leading companies in the region and have access to a vast network of corporate relationships throughout Continental Europe. Greenhill established its presence in Continental Europe in November 2000 with the opening of a Frankfurt office. Greenhill further expanded its presence with the opening of a Madrid office in 2017 and a Paris office in 2020.
For more information on Greenhill’s advisory practice in Continental Europe and our capabilities in the region, please contact President David Wyles in our London office, Managing Director Philip Meyer Horn in our Frankfurt office, Javier Gonzalez in our Madrid Office or Amélie Négrier-Oyarzabal in our Paris office.
Below we highlight a few of the transactions on which we have advised in this region:
Recent Transactions
Sort By
Ventana Medical Systems, Inc.
Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of Ventana Medical Systems, Inc., a US based provider of histopathology diagnostic equipment
E. Brost & J. Funke GmbH & Co. KG (BFK KG) and its 25% stake in Otto Group
Advised the shareholders of BFK KG, comprising the families who also own German publisher WAZ Media Group, on the sale of their 25% holding in German retailing and services group Otto to the Otto family, which thereby regained full ownership of the business
Schenck Process Holding GmbH
Advised HgCapital on the sale of Schenck Process, one of the global market leading providers of industrial weighing, feeding, screening and automation equipment and solutions
DEUTZ Power Systems
Sole advisor to DEUTZ AG on the divestiture of its division DEUTZ Power Systems, a leading manufacturer of gas fired engines for decentralized power generation
SF-Chem AG
Sole advisor to CABB, a leading producer of monochloroacetic acid and related specialty intermediates, on the acquisition of SF-Chem, a manufacturer of chlorine and sulphur specialty intermediates